Cytokinetics, Incorporated ( CYTK) - Stock Earnings
CYTK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -183.0 million USD | 17.8 million USD |
| 2026Q1 | -206.0 million USD | 19.4 million USD |
| 2026Q2 | -198.8 million USD | 31.9 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
CYTK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -526.2 million USD | 7.5 million USD |
| 2024 | -589.5 million USD | 18.5 million USD |
| 2025 | -785.0 million USD | 88.0 million USD |
| 2026 Est. | — | — |
CYTK
Price: $74.13
52 week price:
Earnings Per Share: -7.14 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 998300
Ebitda: -35.8 millionMarket Capitalization: 10.5 billion